|
1
|
Friedlander AH, Sung EC and Child JS:
Radiation-induced heart disease after Hodgkin's disease and breast
cancer treatment: Dental implications. J Am Dent Assoc.
134:1615–1620. 2003. View Article : Google Scholar
|
|
2
|
Rutqvist LE, Rose C and Cavallin-Stahl E:
A systematic overview of radiation therapy effects in breast
cancer. Acta Oncol. 42:532–545. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rutqvist LE, Lax I, Fornander T and
Johansson H: Cardiovascular mortality in a randomized trial of
adjuvant radiation therapy versus surgery alone in primary breast
cancer. Int J Radiat Oncol Biol Phys. 22:887–896. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swerdlow AJ, Higgins CD, Smith P,
Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister A, Radford
JA, Rohatiner AZ and Linch DC: Myocardial infarction mortality risk
after treatment for Hodgkin disease: A collaborative British cohort
study. J Natl Cancer Inst. 99:206–214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Darby SC, Ewertz M, McGale P, Bennet AM,
Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante
B, et al: Risk of ischemic heart disease in women after
radiotherapy for breast cancer. N Engl J Med. 368:987–998. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ismaili N, Elmajjaoui S, Tahri A,
Benjaafar N, Errihani H and Belbaraka R: Trastuzumab in early
breast cancer. Presse Med. 42:1069–1080. 2013.In French. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tukenova M, Guibout C, Oberlin O, Doyon F,
Mousannif A, Haddy N, Guérin S, Pacquement H, Aouba A, Hawkins M,
et al: Role of cancer treatment in long-term overall and
cardiovascular mortality after childhood cancer. J Clin Oncol.
28:1308–1315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Højris I, Overgaard M, Christensen JJ and
Overgaard J: Morbidity and mortality of ischaemic heart disease in
high-risk breast-cancer patients after adjuvant postmastectomy
systemic treatment with or without radiotherapy: Analysis of DBCG
82b and 82c randomised trials. Radiotherapy Committee of the danish
breast cancer cooperative group. Lancet. 354:1425–1430. 1999.
View Article : Google Scholar
|
|
9
|
Seemann I, Gabriels K, Visser NL, Hoving
S, te Poele JA, Pol JF, Gijbels MJ, Janssen BJ, van Leeuwen FW,
Daemen MJ, et al: Irradiation induced modest changes in murine
cardiac function despite progressive structural damage to the
myocardium and microvasculature. Radiother Oncol. 103:143–150.
2012. View Article : Google Scholar
|
|
10
|
Azimzadeh O, Sievert W, Sarioglu H,
Merl-Pham J, Yentrapalli R, Bakshi MV, Janik D, Ueffing M, Atkinson
MJ, Multhoff G and Tapio S: Integrative proteomics and targeted
transcriptomics analyses in cardiac endothelial cells unravel
mechanisms of long-term radiation-induced vascular dysfunction. J
Proteome Res. 14:1203–1219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sanchez-Soria P and Camenisch TD: ErbB
signaling in cardiac development and disease. Semin Cell Dev Biol.
21:929–935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hardenbergh PH, Munley MT, Bentel GC,
Kedem R, Borges-Neto S, Hollis D, Prosnitz LR and Marks LB: Cardiac
perfusion changes in patients treated for breast cancer with
radiation therapy and doxorubicin: Preliminary results. Int J
Radiat Oncol Biol Phys. 49:1023–1028. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marks LB, Yu X, Prosnitz RG, Zhou SM,
Hardenbergh PH, Blazing M, Hollis D, Lind P, Tisch A, Wong TZ and
Borges-Neto S: The incidence and functional consequences of
RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol
Phys. 63:214–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sawyer DB and Caggiano A: Neuregulin-1β
for the treatment of systolic heart failure. J Mol Cell Cardiol.
51:501–505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gui C, Zhu L, Hu M, Lei L and Long Q:
Neuregulin-1/ErbB signaling is impaired in the rat model of
diabetic cardiomyopathy. Cardiovasc Pathol. 21:414–420. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen C, Heusch A, Donner B, Janssen G,
Gobel U and Schmidt KG: Present risk of anthracycline or
radiation-induced cardiac sequelae following therapy of
malignancies in children and adolescents. Klin Padiatr.
221:162–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boulay G and Debaene B: Acute cardiogenic
postoperative edema after doxorubicin (adriamycin) chemotherapy.
Ann Fr Anesth Reanim. 17:43–46. 1998.In French. View Article : Google Scholar
|
|
18
|
Munk M, Memon AA, Goetze JP, Nielsen LB,
Nexo E and Sorensen BS: Hypoxia changes the expression of the
epidermal growth factor (EGF) system in human hearts and cultured
cardiomyocytes. PloS One. 7:e402432012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haas J, Frese KS, Park YJ, Keller A, Vogel
B, Lindroth AM, Weichenhan D, Franke J, Fischer S, Bauer A, et al:
Alterations in cardiac DNA methylation in human dilated
cardiomyopathy. EMBO Mol Med. 5:413–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hernández L, Terradas M, Martín M, Tusell
L and Genescà A: Highly sensitive automated method for DNA damage
assessment: Gamma-H2AX foci counting and cell cycle sorting. Int J
Mol Sci. 14:15810–15826. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gordon LI, Burke MA, Singh AT, Prachand S,
Lieberman ED, Sun L, Naik TJ, Prasad SV and Ardehali H: Blockade of
the erbB2 receptor induces cardiomyocyte death through
mitochondrial and reactive oxygen species-dependent pathways. J
Biol Chem. 284:2080–2087. 2009. View Article : Google Scholar :
|
|
22
|
Dienstmann R, Markman B and Tabernero J:
Application of monoclonal antibodies as cancer therapy in solid
tumors. Curr Clin Pharmacol. 7:137–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marín A, Martín M, Linan O, Alvarenga F,
Lopez M, Fernandez L, Buchser D and Cerezo L: Bystander effects and
radiotherapy. Rep Pract Oncol Radiother. 20:12–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmed FE: Molecular markers that predict
response to colon cancer therapy. Expert Rev Mol Diagn. 5:353–375.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fukazawa R, Miller TA, Kuramochi Y, Frantz
S, Kim YD, Marchionni MA, Kelly RA and Sawyer DB: Neuregulin-1
protects ventricular myocytes from anthracycline-induced apoptosis
via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell
Cardiol. 35:1473–1479. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiao S, Liu B, Gao A, Ye M, Jia X, Zhang
F, Liu H, Shi X and Huang C: Benzo (a)pyrene-caused increased G1-S
transition requires the activation of c-Jun through p53-dependent
PI-3K/Akt/ERK pathway in human embryo lung fibroblasts. Toxicol
Lett. 178:167–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yentrapalli R, Azimzadeh O, Barjaktarovic
Z, Sarioglu H, Wojcik A, Harms-Ringdahl M, Atkinson MJ, Haghdoost S
and Tapio S: Quantitative proteomic analysis reveals induction of
premature senescence in human umbilical vein endothelial cells
exposed to chronic low-dose rate gamma radiation. Proteomics.
13:1096–1107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yentrapalli R, Azimzadeh O, Sriharshan A,
Malinowsky K, Merl J, Wojcik A, Harms-Ringdahl M, Atkinson MJ,
Becker KF, Haghdoost S and Tapio S: The PI3K/Akt/mTOR pathway is
implicated in the premature senescence of primary human endothelial
cells exposed to chronic radiation. PloS One. 8:e700242013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rana MK and Worthylake RA: Novel mechanism
for negatively regulating Rho-kinase (ROCK) signaling through
Coronin1B protein in neuregulin 1 (NRG-1)-induced tumor cell
motility. J Biol Chem. 287:21836–21845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chua YL, Ito Y, Pole JC, Newman S, Chin
SF, Stein RC, Ellis IO, Caldas C, O'Hare MJ, Murrell A and Edwards
PA: The NRG1 gene is frequently silenced by methylation in breast
cancers and is a strong candidate for the 8p tumour suppressor
gene. Oncogene. 28:4041–4052. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Naderi A, Teschendorff AE, Barbosa-Morais
NL, Pinder SE, Green AR, Powe DG, Robertson JF, Aparicio S, Ellis
IO, Brenton JD and Caldas C: A gene-expression signature to predict
survival in breast cancer across independent data sets. Oncogene.
26:1507–1516. 2007. View Article : Google Scholar
|
